| 1 | Hallux valgus (acquired) | FING00000601 | 67.92 |
| 2 | Intraocular pressure (confirmatory factor analysis Factor 26) | GCST90309360 | 64.12 |
| 3 | Autorefraction - 6mm asymmetry index (right) | Eyesight | UKBB00000074 | 60.31 |
| 4 | Intra-ocular pressure, Goldmann-correlated (right) | Intraocular pressure | UKBB00000377 | 59.21 |
| 5 | Pulse pressure | GCST90301703 | 57.09 |
| 6 | HSPG2/IGFBP6 ratio | GCST90315091 | 50.08 |
| 7 | Intra-ocular pressure, Goldmann-correlated (left) | Intraocular pressure | UKBB00000376 | 48.97 |
| 8 | Undecenoylcarnitine (C11:1) levels | GCST90200236 | 48.45 |
| 9 | Hip width to body height ratio | GCST90270260 | 48.29 |
| 10 | Operative procedures - Primary repair of inguinal hernia using insert of prosthetic material | Summary Operations | UKBB00000587 | 47.32 |
| 11 | Pulse pressure | GCST90301701 | 45.91 |
| 12 | Inguinal hernia | FING00000681 | 45.88 |
| 13 | Autorefraction - 6mm weak meridian (left) | Eyesight | UKBB00000079 | 45.46 |
| 14 | Impedance of arm left (UKB data field 23110) | GCST90468171 | 45.14 |
| 15 | Pulse pressure | GCST90472785 | 45.08 |
| 16 | Autorefraction - 6mm strong meridian (left) | Eyesight | UKBB00000075 | 42.94 |
| 17 | Inguinal hernia | digestive | UKBB00000362 | 40.57 |
| 18 | Inguinal hernia | Hernia | UKBB00000363 | 40.29 |
| 19 | IDP dMRI ProbtrackX L3 unc r | GCST90004326 | 39.69 |
| 20 | Impedance of arm right (UKB data field 23109) | GCST90468172 | 39.50 |
| 21 | Autorefraction - 3mm weak meridian (left) | Eyesight | UKBB00000069 | 39.50 |
| 22 | Osteoporosis NOS (PheCode 743.11) | GCST90476260 | 39.26 |
| 23 | Hernia | FING00000616 | 38.99 |
| 24 | Osteoporosis (PheCode 743.1) | GCST90476259 | 38.65 |
| 25 | Autorefraction - 6mm weak meridian (right) | Eyesight | UKBB00000080 | 38.59 |
| 26 | Abdominal hernia | digestive | UKBB00000002 | 38.09 |
| 27 | Abdominal hernia (PheCode 550) | GCST90476059 | 37.66 |
| 28 | ZNRF4 levels | GCST90471104 | 37.18 |
| 29 | Operation code - inguinal/femoral hernia repair | Operations | UKBB00000561 | 36.75 |
| 30 | Autorefraction - 3mm weak meridian (right) | Eyesight | UKBB00000070 | 36.34 |
| 31 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 42) | GCST90320605 | 36.25 |
| 32 | Osteoporosis, osteopenia and pathological fracture (PheCode 743) | GCST90476258 | 36.06 |
| 33 | BCL2 levels | GCST90468433 | 35.75 |
| 34 | Eye conditions (confirmatory factor analysis Factor 25) | GCST90309359 | 35.61 |
| 35 | Dermatochalasis (PheCode 374.6) | GCST90475894 | 35.48 |
| 36 | Haemorrhoidal disease | GCST90014033 | 34.19 |
| 37 | A body shape index | GCST90020024 | 33.95 |
| 38 | Hip index | GCST012229 | 33.86 |
| 39 | Corneal resistance factor | GCST90100568 | 33.52 |
| 40 | CBLN4 levels | GCST90468554 | 32.96 |
| 41 | Impedance of arm (left) | Impedance measures | UKBB00000356 | 32.90 |
| 42 | Impedance of arm (right) | Impedance measures | UKBB00000357 | 32.39 |
| 43 | EFEMP1/FSTL3 ratio | GCST90314595 | 32.36 |
| 44 | Autorefraction - 3mm strong meridian (left) | Eyesight | UKBB00000065 | 32.08 |
| 45 | Phenylalanine levels | GCST90243407 | 32.06 |
| 46 | Oblique pelvic inlet length | GCST90448909 | 32.04 |
| 47 | aparc-DKTatlas rh area inferiorparietal | GCST90003271 | 31.64 |
| 48 | QC T1 inverse SNR | GCST90006348 | 31.61 |
| 49 | Autorefraction - 6mm strong meridian (right) | Eyesight | UKBB00000076 | 31.33 |
| 50 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T3 | ECGU000003 | 31.13 |
| 51 | Waist-hip index | GCST90020027 | 30.78 |
| 52 | TNXB levels | GCST90470930 | 30.77 |
| 53 | REST UKBBICA NET100 1287 | GCST90387141 | 30.38 |
| 54 | Waist circumference adjusted for body mass index | GCST90020029 | 30.12 |
| 55 | IDP dMRI ProbtrackX MD unc l | GCST90004244 | 30.05 |
| 56 | Corneal resistance factor (right) | Intraocular pressure | UKBB00000151 | 29.87 |
| 57 | Operative procedures - Angiocardiography of left side of heart NEC | Summary Operations | UKBB00000572 | 29.78 |
| 58 | Hip index | GCST90020026 | 29.67 |
| 59 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T4 | ECGU000004 | 29.63 |
| 60 | Waist-to-hip ratio adjusted for BMI | GCST90020025 | 29.57 |
| 61 | TNC levels | GCST90470895 | 29.11 |
| 62 | Inguinal hernia (PheCode 550.1) | GCST90476060 | 29.04 |
| 63 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T5 | ECGU000005 | 29.03 |
| 64 | Autorefraction - 3mm strong meridian (right) | Eyesight | UKBB00000066 | 28.83 |
| 65 | Pulse pressure, automated reading | Cardiovascular measurement | UKBB00000714 | 28.82 |
| 66 | Autorefraction - 6mm strong meridian angle (right) | Eyesight | UKBB00000078 | 28.68 |
| 67 | SIL1 levels | GCST90470638 | 28.41 |
| 68 | DTI autoptx L2 str r tract | GCST90385190 | 28.29 |
| 69 | Pulse pressure, automated reading | Cardiovascular measurement | UKBB00000715 | 27.76 |
| 70 | Corneal resistance factor (left) | Intraocular pressure | UKBB00000150 | 27.75 |
| 71 | Pelvic width | GCST90448911 | 27.62 |
| 72 | Right-hemisphere visual network to right-hemisphere control network white-matter structural connectivity | GCST90302779 | 27.51 |
| 73 | ROBO2 levels | GCST90470490 | 27.46 |
| 74 | Pulse pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000718 | 27.41 |
| 75 | Scoliosis | FING00001281 | 27.22 |
| 76 | Fracture of forearm | FING00000554 | 27.22 |
| 77 | Waist-to-hip ratio adjusted for BMI | GCST90025996 | 27.08 |
| 78 | C21orf58 levels | GCST90618380 | 26.86 |
| 79 | Corneal hysteresis (left) | Intraocular pressure | UKBB00000148 | 26.71 |
| 80 | Pulse pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000719 | 26.63 |
| 81 | Carpal tunnel syndrome | FING00000257 | 26.33 |
| 82 | T1 FreeSurfer DKT rh fusiform thickness | GCST90384322 | 26.29 |
| 83 | aseg global volume-ratio BrainSegVol-to-eTIV | GCST90002612 | 26.05 |
| 84 | Corneal resistance factor | GCST90308682 | 25.87 |
| 85 | Dupuytren's disease | GCST90301252 | 25.82 |
| 86 | CNTN1 levels | GCST90468803 | 25.63 |
| 87 | Incisional hernia (PheCode 550.6) | GCST90476064 | 25.45 |
| 88 | aparc-Desikan rh area inferiorparietal | GCST90003114 | 25.32 |
| 89 | aparc-Desikan lh thickness postcentral | GCST90003466 | 25.26 |
| 90 | IDP T1 FAST ROIs R occ pole | GCST90002546 | 25.26 |
| 91 | Iliac isthmus breadth | GCST90448907 | 25.17 |
| 92 | Pulse pressure | GCST90301702 | 25.12 |
| 93 | aparc-pial rh area inferiorparietal | GCST90003181 | 25.12 |
| 94 | SCARA5 levels | GCST90470533 | 24.78 |
| 95 | Prescriptions - latanoprost | prostaglandin analog | UKBB00000686 | 24.75 |
| 96 | CXCL10/WARS ratio | GCST90314332 | 24.39 |
| 97 | Autorefraction - 3mm strong meridian angle (left) | Eyesight | UKBB00000067 | 24.20 |
| 98 | IDP dMRI ProbtrackX MD unc r | GCST90004245 | 24.19 |
| 99 | Ventral hernia (PheCode 550.5) | GCST90476063 | 24.18 |
| 100 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 89) | GCST90320652 | 24.16 |
| 101 | Impedance of whole body (UKB data field 23106) | GCST90468173 | 24.01 |
| 102 | Autorefraction - 6mm asymmetry index (left) | Eyesight | UKBB00000073 | 24.00 |
| 103 | EGFR/FAP ratio | GCST90314613 | 23.97 |
| 104 | IDP dMRI ProbtrackX L2 unc r | GCST90004299 | 23.94 |
| 105 | VNN2 levels | GCST90618510 | 23.89 |
| 106 | aparc-a2009s lh thickness G-postcentral | GCST90003630 | 23.44 |
| 107 | IDP dMRI ProbtrackX L3 unc l | GCST90004325 | 23.39 |
| 108 | EIF4G1/TBC1D23 ratio | GCST90314639 | 23.24 |
| 109 | Other mental disorders due to brain damage and dysfunction and to physical disease | FING00001072 | 23.17 |
| 110 | IDP dMRI ProbtrackX MO str r | GCST90004024 | 23.13 |
| 111 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T2 | ECGU000002 | 23.10 |
| 112 | Volume of right accessory basal nucleus | GCST90475006 | 22.70 |
| 113 | Heel bone mineral density (BMD) (right) | Bone-densitometry of heel | UKBB00000314 | 22.51 |
| 114 | Waist-hip index | GCST012228 | 22.39 |
| 115 | Corneal hysteresis (right) | Intraocular pressure | UKBB00000149 | 22.38 |
| 116 | AGRN/HSPG2 ratio | GCST90313201 | 22.31 |
| 117 | IDP dMRI ProbtrackX FA unc r | GCST90003951 | 22.16 |
| 118 | IDP dMRI TBSS L3 Cerebral peduncle R | GCST90004185 | 22.13 |
| 119 | Pulse pressure | GCST90472783 | 21.99 |
| 120 | Cereal type - Oat cereal (e.g. Ready Brek, porridge) | Diet | UKBB00000124 | 21.95 |
| 121 | Heel quantitative ultrasound index (QUI), direct entry (right) | Bone-densitometry of heel | UKBB00000323 | 21.87 |
| 122 | Heel bone mineral density (BMD) T-score, automated (right) | Bone-densitometry of heel | UKBB00000317 | 21.87 |
| 123 | Central corneal thickness | GCST006366 | 21.86 |
| 124 | COL18A1 levels | GCST90468812 | 21.67 |
| 125 | CCN3/FAP ratio | GCST90313721 | 21.64 |
| 126 | Blood cell traits latent factor 21 (red cell) | GCST90559263 | 21.49 |
| 127 | Autorefraction - 3mm cylindrical power (left) | Eyesight | UKBB00000062 | 21.38 |
| 128 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 54) | GCST90320873 | 21.30 |
| 129 | wg lh intensity-contrast middletemporal | GCST90003806 | 21.27 |
| 130 | MCEE levels | GCST90469871 | 21.22 |
| 131 | Ribothymidine levels in chronic kidney disease | GCST90257554 | 21.21 |
| 132 | Waist-to-hip ratio adjusted for BMI | GCST012230 | 21.14 |
| 133 | Intrahepatic cholestasis of pregnancy | GCST90454199 | 21.11 |
| 134 | Female genital prolapse | FING00000535 | 20.94 |
| 135 | Primary open-angle glaucoma, strict | FING00001214 | 20.85 |
| 136 | COL6A3/SMOC2 ratio | GCST90314178 | 20.82 |
| 137 | DTI autoptx FA str r tract | GCST90385136 | 20.82 |
| 138 | Open-angle glaucoma (PheCode 365.1) | GCST90475872 | 20.79 |
| 139 | ROBO2/SCARF2 ratio | GCST90315784 | 20.74 |
| 140 | aparc-a2009s rh volume G-front-inf-Triangul | GCST90003012 | 20.74 |
| 141 | COL6A3/CST3 ratio | GCST90314174 | 20.73 |
| 142 | aparc-DKTatlas lh thickness postcentral | GCST90003560 | 20.56 |
| 143 | Heel bone mineral density (BMD) (left) | Bone-densitometry of heel | UKBB00000313 | 20.52 |
| 144 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T8 | ECGU000008 | 20.51 |
| 145 | Impedance of whole body | Impedance measures | UKBB00000360 | 20.46 |
| 146 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T6 | ECGU000006 | 20.45 |
| 147 | IDP dMRI ProbtrackX MD cgh l | GCST90004225 | 20.39 |
| 148 | Glaucoma | GCST90475869 | 20.39 |
| 149 | Operation code - squint correction | Operations | UKBB00000566 | 20.37 |
| 150 | CTSO/IGF2R ratio | GCST90314317 | 20.27 |
| 151 | DTI autoptx L3 str r tract | GCST90385217 | 20.25 |
| 152 | Waist circumference adjusted for body mass index | GCST90302892 | 20.11 |
| 153 | IDP dMRI ProbtrackX MD ar l | GCST90004219 | 19.95 |
| 154 | Pulse pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000716 | 19.86 |
| 155 | Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000720 | 19.59 |
| 156 | Pulse pressure | GCST90310296 | 19.57 |
| 157 | Pulse pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000717 | 19.54 |
| 158 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T9 | ECGU000009 | 19.27 |
| 159 | Alzheimer's disease (MTAG) | GCST90449055 | 19.25 |
| 160 | Atherosclerosis of native arteries of the extremities with intermittent claudication (PheCode 440.22) | GCST90475991 | 19.20 |
| 161 | Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000721 | 19.14 |
| 162 | Delta body mass index (difference between ECG-predicted and measured) | GCST90429062 | 18.79 |
| 163 | Contracture of palmar fascia [Dupuytren's disease] | musculoskeletal | UKBB00000146 | 18.74 |
| 164 | SCARA5/TNC ratio | GCST90315810 | 18.72 |
| 165 | CPM levels | GCST90240598 | 18.71 |
| 166 | Glaucoma | GCST90018632 | 18.65 |
| 167 | Subclinical hyperthyroidism in pregnancy | GCST90435199 | 18.63 |
| 168 | Heel quantitative ultrasound index (QUI), direct entry (left) | Bone-densitometry of heel | UKBB00000322 | 18.63 |
| 169 | Heel bone mineral density (BMD) T-score, automated (left) | Bone-densitometry of heel | UKBB00000316 | 18.62 |
| 170 | DTI TBSS L1 External capsule R | GCST90384460 | 18.47 |
| 171 | SSC5D levels | GCST90470748 | 18.43 |
| 172 | Calcific aortic valve stenosis | GCST90310293 | 18.30 |
| 173 | Takes medication for Glaucoma? | GCST90475384 | 18.29 |
| 174 | DTI TBSS FA Posterior corona radiata R | GCST90384406 | 18.25 |
| 175 | PILRA/TNFRSF1A ratio | GCST90315655 | 18.07 |
| 176 | 1-stearoyl-2-arachidonoyl-GPC (18:0/20:4) metabolite level | GCST90615670 | 17.90 |
| 177 | RBP5 levels | GCST90470439 | 17.88 |
| 178 | Descending aorta diameter | GCST90267391 | 17.86 |
| 179 | Glaucoma | GCST90475383 | 17.77 |
| 180 | MATN2/SCARA5 ratio | GCST90315388 | 17.61 |
| 181 | Takes medication for Macular Degeneration? | GCST90475387 | 17.58 |
| 182 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T28 | ECGA000028 | 17.54 |
| 183 | CLMP/PIK3IP1 ratio | GCST90314134 | 17.49 |
| 184 | Other specified and unspecified disorders of lens | FING00001101 | 17.47 |
| 185 | TNC/VCAM1 ratio | GCST90315927 | 17.43 |
| 186 | X-25371 levels | GCST90200656 | 17.36 |
| 187 | IGFBP6/SMOC2 ratio | GCST90315138 | 17.36 |
| 188 | Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 3.04_132.06) | GCST90291582 | 17.32 |
| 189 | IDP dMRI TBSS MD External capsule L | GCST90004060 | 17.31 |
| 190 | BA-exvivo lh thickness BA2 | GCST90003514 | 17.28 |
| 191 | DTI TBSS MD Cingulum hippocampus R | GCST90384608 | 17.27 |
| 192 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T7 | ECGU000007 | 17.19 |
| 193 | Tibia length to body height ratio | GCST90270258 | 17.04 |
| 194 | Pelvic inlet width | GCST90448910 | 16.97 |
| 195 | FOLH1 levels | GCST90427192 | 16.96 |
| 196 | Disorders of muscle, ligament, and fascia | musculoskeletal | UKBB00000187 | 16.93 |
| 197 | Heel Broadband ultrasound attenuation, direct entry | Bone-densitometry of heel | UKBB00000321 | 16.89 |
| 198 | Indolelactate levels | GCST90243507 | 16.76 |
| 199 | CCDC80/CCL27 ratio | GCST90313669 | 16.68 |
| 200 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 82) | GCST90320645 | 16.64 |
| 201 | Impedance of leg (left) | Impedance measures | UKBB00000358 | 16.62 |
| 202 | Hallux valgus (Bunion) | musculoskeletal | UKBB00000299 | 16.57 |
| 203 | IDP dMRI ProbtrackX L1 unc l | GCST90004271 | 16.54 |
| 204 | Serine levels | GCST90200415 | 16.53 |
| 205 | aparc-DKTatlas lh thickness cuneus | GCST90003543 | 16.44 |
| 206 | aparc-Desikan lh thickness cuneus | GCST90003449 | 16.43 |
| 207 | HSPG2/SMOC2 ratio | GCST90315093 | 16.33 |
| 208 | BA-exvivo rh thickness BA1 | GCST90003527 | 16.32 |
| 209 | 4-hydroxyglutamate levels | GCST90199890 | 16.29 |
| 210 | Occlusion and stenosis of precerebral arteries (PheCode 433.1) | GCST90475986 | 16.17 |
| 211 | wg lh intensity-contrast superiortemporal | GCST90003821 | 16.13 |
| 212 | Hallux valgus (Bunion) (PheCode 735.3) | GCST90476251 | 16.04 |
| 213 | LTB4R levels | GCST90422164 | 16.00 |
| 214 | Sleep apnea (MTAG) (adjusted for BMI) | GCST90267364 | 15.99 |
| 215 | aparc-a2009s lh thickness G-cuneus | GCST90003613 | 15.92 |
| 216 | Ankle spacing width | Bone-densitometry of heel | UKBB00000035 | 15.91 |
| 217 | COL6A3/COLEC12 ratio | GCST90314173 | 15.90 |
| 218 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 2) | GCST90320821 | 15.87 |
| 219 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 11) | GCST90320574 | 15.86 |
| 220 | Subpubic angle | GCST90448908 | 15.86 |
| 221 | SLITRK6 levels | GCST90470671 | 15.78 |
| 222 | Umbilical hernia (PheCode 550.4) | GCST90476062 | 15.73 |
| 223 | IDP dMRI ProbtrackX FA ilf l | GCST90003939 | 15.62 |
| 224 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 43) | GCST90320606 | 15.61 |
| 225 | Autorefraction - 3mm strong meridian angle (right) | Eyesight | UKBB00000068 | 15.59 |
| 226 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 58) | GCST90320621 | 15.56 |
| 227 | Medication use (salicylic acid and derivatives) | GCST90018775 | 15.52 |
| 228 | CD200R1 levels | GCST90468605 | 15.51 |
| 229 | IDP dMRI ProbtrackX L2 unc l | GCST90004298 | 15.46 |
| 230 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T1 | ECGU000001 | 15.43 |
| 231 | Gout (PheCode 274.1) | GCST90043662 | 15.42 |
| 232 | Glaucoma | GCST90468129 | 15.40 |
| 233 | Glaucoma (multi-trait analysis) | GCST009722 | 15.37 |
| 234 | Hereditary deficiency of other clotting factors | FING00000612 | 15.33 |
| 235 | AGRN/BTN2A1 ratio | GCST90313199 | 15.17 |
| 236 | aparc-a2009s lh volume G-cuneus | GCST90002935 | 15.16 |
| 237 | Keloid | GCST90652488 | 15.15 |
| 238 | Impedance of leg (right) | Impedance measures | UKBB00000359 | 15.12 |
| 239 | BA-exvivo lh thickness BA4p | GCST90003518 | 15.09 |
| 240 | Prescriptions - prostaglandin analog | UKBB00000697 | 15.08 |
| 241 | LGALS3 levels | GCST90179303 | 15.06 |
| 242 | DTI TBSS L3 Superior corona radiata R | GCST90384548 | 15.03 |
| 243 | Deforming dorsopathies | FING00000385 | 14.99 |
| 244 | IFIT2 levels | GCST90090864 | 14.95 |
| 245 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 68) | GCST90320631 | 14.88 |
| 246 | Volume of left basal nucleus | GCST90474946 | 14.83 |
| 247 | Contracture of palmar fascia [Dupuytren's disease] (PheCode 728.71) | GCST90476245 | 14.82 |
| 248 | DTI TBSS L2 Posterior corona radiata L | GCST90384503 | 14.72 |
| 249 | AOC3 levels | GCST90468322 | 14.69 |
| 250 | Waist-to-Hip ratio | Body measurement | UKBB00000905 | 14.66 |
| 251 | Waist circumference adjusted for body mass index | GCST012226 | 14.57 |
| 252 | Angina | GCST90468109 | 14.57 |
| 253 | Forced vital capacity FVC Z score (UKB data field 20257) | GCST90468167 | 14.57 |
| 254 | COL6A3/HSPG2 ratio | GCST90314175 | 14.56 |
| 255 | aparc-a2009s lh volume S-central | GCST90002969 | 14.55 |
| 256 | Bone density (confirmatory factor analysis Factor 19) | GCST90309353 | 14.53 |
| 257 | BA-exvivo lh area entorhinal | GCST90003220 | 14.47 |
| 258 | C7 levels | GCST90422332 | 14.46 |
| 259 | ThalamNuclei rh volume CeM | GCST90002751 | 14.45 |
| 260 | aparc-pial rh area lateraloccipital | GCST90003184 | 14.39 |
| 261 | CASP1 levels | GCST90468543 | 14.39 |
| 262 | DLK1/FAP ratio | GCST90314491 | 14.38 |
| 263 | EGFR levels | GCST90469085 | 14.34 |
| 264 | DNAJA2/PLXNA4 ratio | GCST90314504 | 14.22 |
| 265 | Maximum carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasound | UKBB00000429 | 14.21 |
| 266 | Macular degeneration, wet (PheCode 362.22) | GCST90475852 | 14.20 |
| 267 | Triacylglycerol (54:1) [NL-18:1] levels | GCST90024563 | 14.12 |
| 268 | GAPDH levels | GCST90469302 | 14.12 |
| 269 | Mean volume of bilateral amygdala | GCST90474994 | 14.10 |
| 270 | IDP dMRI ProbtrackX L2 ilf l | GCST90004287 | 14.09 |
| 271 | Glaucoma (primary open-angle) | GCST90011768 | 14.06 |
| 272 | Heel broadband ultrasound attenuation (left) | Bone-densitometry of heel | UKBB00000319 | 14.03 |
| 273 | SRPX levels | GCST90470744 | 13.93 |
| 274 | Operative procedures - Palmar fasciectomy | Summary Operations | UKBB00000586 | 13.79 |
| 275 | BOC levels | GCST90468458 | 13.76 |
| 276 | Heart rate variability traits (SDNN) | GCST004734 | 13.75 |
| 277 | Diaphragmatic hernia | FING00000419 | 13.74 |
| 278 | FAP levels | GCST90469189 | 13.66 |
| 279 | CD69/CDKN2D ratio | GCST90313866 | 13.60 |
| 280 | Age-related eyesight deterioration (confirmatory factor analysis Factor 27) | GCST90309361 | 13.59 |
| 281 | Hypertrophy of breast | FING00000644 | 13.59 |
| 282 | A body shape index | GCST012231 | 13.52 |
| 283 | Diaphragmatic hernia (PheCode 550.2) | GCST90476061 | 13.47 |
| 284 | Acquired absence of organs, not elsewhere classified | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000005 | 13.44 |
| 285 | COMP/MYOC ratio | GCST90314191 | 13.43 |
| 286 | Descending aorta distensibility | GCST90267386 | 13.40 |
| 287 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 64) | GCST90320883 | 13.34 |
| 288 | Primary open angle glaucoma (PheCode 365.11) | GCST90475875 | 13.29 |
| 289 | Osteoporosis | GCST90468145 | 13.28 |
| 290 | Coronary artery calcification | GCST90278456 | 13.25 |
| 291 | Body fat percentage (adjusted for testosterone and SHBG) | GCST90432179 | 13.22 |
| 292 | HSPG2 levels | GCST90469491 | 13.19 |
| 293 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T29 | ECGA000029 | 13.16 |
| 294 | Ganglion | FING00000563 | 13.14 |
| 295 | FST levels | GCST90469273 | 13.12 |
| 296 | LGALS3 levels | GCST90469761 | 13.08 |
| 297 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78) | GCST90320897 | 13.06 |
| 298 | DTI TBSS L3 Cingulum hippocampus R | GCST90384560 | 12.99 |
| 299 | Volume of left paralaminar nucleus | GCST90474982 | 12.97 |
| 300 | ANGPTL7 levels | GCST90468306 | 12.97 |
| 301 | Sphingomyelin_42:2_[M+H]1+ levels | GCST90060403 | 12.93 |
| 302 | COL6A3/OGN ratio | GCST90314177 | 12.92 |
| 303 | Nonrheumatic aortic valve disorders (PheCode 395.2) | GCST90475914 | 12.87 |
| 304 | aparc-DKTatlas rh area lateraloccipital | GCST90003274 | 12.85 |
| 305 | GBP2 levels | GCST90469312 | 12.82 |
| 306 | Illnesses of father - Heart disease | Family history | UKBB00000342 | 12.80 |
| 307 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 90) | GCST90320909 | 12.71 |
| 308 | Myopia (PheCode 367.1) | GCST90475880 | 12.70 |
| 309 | CDON/SCARA5 ratio | GCST90313995 | 12.68 |
| 310 | Low hand grip strength (60 years and older) (EWGSOP) | GCST90007526 | 12.66 |
| 311 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 34) | GCST90320597 | 12.64 |
| 312 | Pulse pressure | GCST90472784 | 12.63 |
| 313 | Appendicular lean mass | GCST90000027 | 12.63 |
| 314 | GGCT levels | GCST90469334 | 12.62 |
| 315 | DTI TBSS L3 Superior corona radiata L | GCST90384549 | 12.61 |
| 316 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T27 | ECGA000027 | 12.59 |
| 317 | Levulinate 4-oxovalerate levels | GCST90243545 | 12.57 |
| 318 | Heel bone mineral density (BMD) T-score, automated | Bone-densitometry of heel | UKBB00000318 | 12.56 |
| 319 | Heel quantitative ultrasound index (QUI), direct entry | Bone-densitometry of heel | UKBB00000324 | 12.56 |
| 320 | DTI TBSS L1 Splenium of corpus callosum | GCST90384432 | 12.56 |
| 321 | Heel bone mineral density (BMD) | Bone-densitometry of heel | UKBB00000315 | 12.51 |
| 322 | Sulcal opening distance of the right calloso-marginal posterior fissure | GCST90104946 | 12.48 |
| 323 | Hand grip strength right (UKB data field 47) | GCST90468169 | 12.41 |
| 324 | Aortic aneurysm (PheCode 442.1) | GCST90475993 | 12.38 |
| 325 | IDP dMRI ProbtrackX MO str l | GCST90004023 | 12.37 |
| 326 | EFEMP1/TGFBR3 ratio | GCST90314597 | 12.29 |
| 327 | Macular puckering of retina (PheCode 362.26) | GCST90475854 | 12.26 |
| 328 | DTI TBSS L2 Posterior corona radiata R | GCST90384502 | 12.25 |
| 329 | IDP dMRI ProbtrackX L3 ilf r | GCST90004315 | 12.16 |
| 330 | BA-exvivo lh thickness BA4a | GCST90003517 | 12.16 |
| 331 | Fibroblastic disorders | Other soft tissue disorders | UKBB00000246 | 12.13 |
| 332 | Macular degeneration | GCST90475386 | 12.10 |
| 333 | TNN levels | GCST90470927 | 12.10 |
| 334 | Mean carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasound | UKBB00000446 | 12.00 |
| 335 | Intra-ocular pressure, corneal-compensated (left) | Intraocular pressure | UKBB00000374 | 11.97 |
| 336 | BA-exvivo lh volume entorhinal | GCST90002848 | 11.91 |
| 337 | Fasciitis | musculoskeletal | UKBB00000239 | 11.91 |
| 338 | Illnesses of siblings - Heart disease | Family history | UKBB00000351 | 11.91 |
| 339 | FSTL3/SPON2 ratio | GCST90314884 | 11.88 |
| 340 | Prescriptions - anti-malarial | UKBB00000663 | 11.87 |
| 341 | Prescriptions - quinine bisulfate | anti-malarial | UKBB00000698 | 11.87 |
| 342 | CHL1 levels | GCST90468745 | 11.85 |
| 343 | ANGPTL2 levels | GCST90468303 | 11.80 |
| 344 | Lymphoplasmacytic lymphoma and Waldenstrom macroglobulinemia | GCST90624744 | 11.78 |
| 345 | 1-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levels | GCST90200692 | 11.78 |
| 346 | Macular degeneration (senile) of retina NOS (PheCode 362.29) | GCST90475857 | 11.72 |
| 347 | Heel broadband ultrasound attenuation (right) | Bone-densitometry of heel | UKBB00000320 | 11.69 |
| 348 | DTI autoptx MD unc l tract | GCST90385245 | 11.69 |
| 349 | POSTN levels | GCST90470288 | 11.68 |
| 350 | wg rh intensity-contrast parahippocampal | GCST90003842 | 11.67 |
| 351 | Other aneurysm (PheCode 442) | GCST90475992 | 11.60 |
| 352 | Volume of left whole amygdala | GCST90474988 | 11.57 |
| 353 | IDP T1 FAST ROIs V cerebellum VIIIa | GCST90002579 | 11.54 |
| 354 | VWF levels | GCST90471065 | 11.52 |
| 355 | VCAN levels | GCST90471032 | 11.52 |
| 356 | Calcific aortic valvular stenosis, operated | FING00000234 | 11.50 |
| 357 | Rotator cuff injury | GCST90044700 | 11.49 |
| 358 | Operation code - haemorroidectomy / piles surgery/ banding of piles | Operations | UKBB00000557 | 11.48 |
| 359 | Benign neoplasm: Adrenal gland | FING00000164 | 11.48 |
| 360 | IDP dMRI ProbtrackX MD ilf l | GCST90004233 | 11.44 |
| 361 | aparc-a2009s lh thickness S-postcentral | GCST90003669 | 11.43 |
| 362 | Diverticular disease of intestine | Other diseases of intestines | UKBB00000189 | 11.42 |
| 363 | Fracture of forearm | GCST90281273 | 11.29 |
| 364 | IDP T1 FAST ROIs L front operc cortex | GCST90002531 | 11.24 |
| 365 | MAVS/PPP1R9B ratio | GCST90315393 | 11.22 |
| 366 | MATN2 levels | GCST90469864 | 11.21 |
| 367 | BPIFB1/GLRX ratio | GCST90313530 | 11.20 |
| 368 | CD59/SCARB2 ratio | GCST90313859 | 11.17 |
| 369 | Biological Sibling: Alzheimer's / Other Dementia | GCST90476375 | 11.16 |
| 370 | IDP dMRI ProbtrackX MD ilf r | GCST90004234 | 11.15 |
| 371 | PTPRF/PTPRS ratio | GCST90315751 | 11.12 |
| 372 | FAP/LRRN1 ratio | GCST90314783 | 11.11 |
| 373 | X-18601 levels | GCST90243501 | 11.11 |
| 374 | PLXDC1 levels | GCST90470263 | 11.09 |
| 375 | IDP T1 FIRST left putamen volume | GCST90002440 | 11.07 |
| 376 | Descending aorta strain | GCST90267389 | 11.06 |
| 377 | aparc-a2009s rh volume S-central | GCST90003043 | 11.02 |
| 378 | Acquired foot deformities | musculoskeletal | UKBB00000007 | 11.02 |
| 379 | Left-hemisphere somatomotor network to thalamus white-matter structural connectivity | GCST90302682 | 11.01 |
| 380 | diastolic blood pressure (DBP, mean, inv-normal transformed) | GCST90475255 | 11.00 |
| 381 | RFC4 levels | GCST90470460 | 10.98 |
| 382 | Forced expiratory volume in 1-second (FEV1), predicted | Spirometry | UKBB00000252 | 10.92 |
| 383 | Intra-ocular pressure, corneal-compensated (right) | Intraocular pressure | UKBB00000375 | 10.91 |
| 384 | Intestinal infectious diseases | FING00000689 | 10.90 |
| 385 | Acquired deformities of fingers and toes | Other joint disorders | UKBB00000006 | 10.87 |
| 386 | FOXJ3 levels | GCST90469264 | 10.86 |
| 387 | Volume of right cortico-amygdaloid transition area | GCST90474913 | 10.86 |
| 388 | BA-exvivo rh volume BA4p | GCST90002854 | 10.85 |
| 389 | wg rh intensity-contrast parstriangularis | GCST90003846 | 10.85 |
| 390 | X-24337 levels | GCST90200629 | 10.84 |
| 391 | Right-hemisphere somatomotor network to thalamus white-matter structural connectivity | GCST90302794 | 10.78 |
| 392 | IDP dMRI TBSS MD Retrolenticular part of internal capsule R | GCST90004047 | 10.69 |
| 393 | Diverticulosis and diverticulitis | digestive | UKBB00000191 | 10.63 |
| 394 | TXN levels | GCST90470995 | 10.62 |
| 395 | C-reactive protein levels (CRP.4337.49.2) | GCST90240503 | 10.58 |
| 396 | IDP dMRI TBSS MD Retrolenticular part of internal capsule L | GCST90004048 | 10.58 |
| 397 | Other disorders of testis (PheCode 603) | GCST90476156 | 10.57 |
| 398 | Ankle spacing width (right) | Bone-densitometry of heel | UKBB00000034 | 10.55 |
| 399 | Medication use (antithrombotic agents) | GCST90018762 | 10.54 |
| 400 | IDP dMRI ProbtrackX L3 ilf l | GCST90004314 | 10.53 |
| 401 | aparc-Desikan rh area lateraloccipital | GCST90003117 | 10.52 |
| 402 | IDP dMRI ProbtrackX L3 ifo l | GCST90004312 | 10.50 |
| 403 | FST/FSTL3 ratio | GCST90314882 | 10.50 |
| 404 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 128) | GCST90320691 | 10.49 |
| 405 | IDP dMRI TBSS MD External capsule R | GCST90004059 | 10.49 |
| 406 | IDP dMRI ProbtrackX L3 ifo r | GCST90004313 | 10.47 |
| 407 | Diverticulosis | digestive | UKBB00000190 | 10.43 |
| 408 | Haemorrhoids and perianal venous thrombosis | FING00000599 | 10.42 |
| 409 | aparc-DKTatlas lh thickness precentral | GCST90003562 | 10.41 |
| 410 | Height | GCST90278637 | 10.41 |
| 411 | DTI autoptx L3 unc l tract | GCST90385218 | 10.39 |
| 412 | Glaucoma (primary open-angle) | GCST90399725 | 10.36 |
| 413 | NHLRC3 levels | GCST90470046 | 10.35 |
| 414 | IDP dMRI ProbtrackX MD cst l | GCST90004227 | 10.34 |
| 415 | Nonalcoholic fatty liver disease | GCST90054782 | 10.31 |
| 416 | PER3 levels | GCST90470210 | 10.31 |
| 417 | CCN3 levels | GCST90468589 | 10.30 |
| 418 | IFIT3 levels | GCST90241571 | 10.28 |
| 419 | RET levels | GCST90470458 | 10.25 |
| 420 | Synovitis and tenosynovitis (PheCode 727.1) | GCST90476242 | 10.25 |
| 421 | Ascending aorta strain | GCST90267388 | 10.21 |
| 422 | aparc-Desikan lh thickness precentral | GCST90003468 | 10.21 |
| 423 | Hip circumference adjusted for BMI | GCST012227 | 10.20 |
| 424 | IDP T1 FAST ROIs L caudate | GCST90002549 | 10.16 |
| 425 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T33 | ECGA000033 | 10.14 |
| 426 | Palmar fascial fibromatosis [Dupuytren] | FING00001141 | 10.14 |
| 427 | Aortic aneurysm | FING00000102 | 10.11 |
| 428 | IL1RL1 levels | GCST90241581 | 10.11 |
| 429 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T10 | ECGU000010 | 10.08 |
| 430 | Glucose levels | GCST90132724 | 10.04 |
| 431 | Low hand grip strength (60 years and older) (EWGSOP) | GCST90007527 | 10.03 |
| 432 | SCAMP3/VPS53 ratio | GCST90315807 | 10.02 |
| 433 | Triacylglycerol_53:5_[M+NH4]1+ levels | GCST90060520 | 9.96 |
| 434 | IDP dMRI TBSS MD Superior fronto-occipital fasciculus L | GCST90004070 | 9.95 |
| 435 | aparc-a2009s lh thickness G-precuneus | GCST90003632 | 9.93 |
| 436 | IDP dMRI TBSS L1 External capsule L | GCST90004108 | 9.92 |
| 437 | wg rh intensity-contrast temporalpole | GCST90003859 | 9.88 |
| 438 | Free testosterone levels | GCST90239826 | 9.87 |
| 439 | Hypertrophy of breast in women and men | FING00000645 | 9.87 |
| 440 | DPP6/SEZ6L2 ratio | GCST90314543 | 9.87 |
| 441 | IDP dMRI TBSS L3 External capsule L | GCST90004204 | 9.86 |
| 442 | PSAP levels | GCST90426586 | 9.85 |
| 443 | Hair/balding pattern: Pattern 4 (UKB data field 2395_4) | GCST90043619 | 9.84 |
| 444 | Left hippocampal volume (tail) | GCST90267951 | 9.82 |
| 445 | Anterior thigh muscle fat infiltration percentage | GCST90267351 | 9.81 |
| 446 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 37) | GCST90320856 | 9.80 |
| 447 | Female genital prolapse | Noninflammatory disorders of female genital tract | UKBB00000244 | 9.79 |
| 448 | Lung function (FVC) | GCST007429 | 9.77 |
| 449 | PRELP levels | GCST90470321 | 9.75 |
| 450 | Right hippocampal volume | GCST90267974 | 9.75 |
| 451 | Heel bone mineral density | GCST006288 | 9.74 |
| 452 | IDP dMRI TBSS L3 External capsule R | GCST90004203 | 9.72 |
| 453 | aparc-a2009s rh area Pole-occipital | GCST90003412 | 9.72 |
| 454 | OCLN levels | GCST90470114 | 9.71 |
| 455 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121) | GCST90320940 | 9.70 |
| 456 | MUC16 levels | GCST90469964 | 9.70 |
| 457 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 77) | GCST90320896 | 9.70 |
| 458 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T366 | ECGU000366 | 9.67 |
| 459 | IDP dMRI TBSS L1 Superior fronto-occipital fasciculus R | GCST90004117 | 9.67 |
| 460 | BA-exvivo lh thickness BA3b | GCST90003516 | 9.67 |
| 461 | Hand grip strength left (UKB data field 46) | GCST90468168 | 9.65 |
| 462 | COMP/DPP4 ratio | GCST90314188 | 9.63 |
| 463 | BA-exvivo lh thickness BA1 | GCST90003513 | 9.59 |
| 464 | IDP T1 FAST ROIs L intracalc cortex | GCST90002497 | 9.57 |
| 465 | Umbilical hernia | digestive | UKBB00000880 | 9.57 |
| 466 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 118) | GCST90320937 | 9.57 |
| 467 | Appendicular lean mass | GCST90000025 | 9.54 |
| 468 | REG4/SPINK4 ratio | GCST90315766 | 9.53 |
| 469 | FUT8/TNFSF14 ratio | GCST90314895 | 9.51 |
| 470 | aparc-a2009s lh volume G-precentral | GCST90002953 | 9.46 |
| 471 | Degree of unsaturation | GCST90502224 | 9.45 |
| 472 | Other disorders of eyelids (PheCode 374) | GCST90475890 | 9.45 |
| 473 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 105) | GCST90320924 | 9.44 |
| 474 | IDP dMRI TBSS OD Superior fronto-occipital fasciculus L | GCST90004445 | 9.43 |
| 475 | COLEC12/OGN ratio | GCST90314184 | 9.41 |
| 476 | BAMBI levels | GCST90468420 | 9.40 |
| 477 | Volume of right basal nucleus | GCST90475012 | 9.38 |
| 478 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 51) | GCST90320614 | 9.37 |
| 479 | Blepharochalasis | FING00000220 | 9.37 |
| 480 | Retinal thickness (functional principal component 2) | GCST90455722 | 9.36 |
| 481 | MAMDC2 levels | GCST90469841 | 9.36 |
| 482 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T365 | ECGU000365 | 9.35 |
| 483 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 47) | GCST90320866 | 9.35 |
| 484 | ARF6 levels | GCST90468348 | 9.33 |
| 485 | IDP T1 FAST ROIs L cuneal cortex | GCST90002513 | 9.33 |
| 486 | IDP dMRI ProbtrackX L2 ilf r | GCST90004288 | 9.31 |
| 487 | Coronary artery calcification | GCST90503074 | 9.31 |
| 488 | NIT1 levels | GCST90470050 | 9.28 |
| 489 | Aplastic anemia | GCST90018574 | 9.27 |
| 490 | PALM2 levels | GCST90470152 | 9.27 |
| 491 | SNX2 levels | GCST90470701 | 9.26 |
| 492 | ThalamNuclei rh volume VAmc | GCST90002747 | 9.26 |
| 493 | aseg global volume WM-hypointensities | GCST90002604 | 9.25 |
| 494 | FHIT/PARK7 ratio | GCST90314821 | 9.25 |
| 495 | BA-exvivo lh volume BA6 | GCST90002841 | 9.25 |
| 496 | Diverticulosis and diverticulitis (PheCode 562) | GCST90476073 | 9.23 |
| 497 | Hippocampal subfield right CA1 volume (head) | GCST90267961 | 9.21 |
| 498 | Treatment/medication code - co-codamol | Medications | UKBB00000845 | 9.16 |
| 499 | PTPRN2/RTBDN ratio | GCST90315754 | 9.16 |
| 500 | Endometriosis of ovary | FING00000501 | 9.10 |
| 501 | Umbilical hernia | Hernia | UKBB00000881 | 9.09 |
| 502 | DTI TBSS L3 Anterior corona radiata L | GCST90384547 | 9.06 |
| 503 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 46) | GCST90320609 | 9.06 |
| 504 | aparc-Desikan lh volume precentral | GCST90002791 | 9.06 |
| 505 | Snoring | GCST009761 | 9.04 |
| 506 | aparc-Desikan rh thickness postcentral | GCST90003500 | 9.04 |
| 507 | NPL levels | GCST90470072 | 9.04 |
| 508 | BCAT1 levels | GCST90468427 | 9.04 |
| 509 | INHBC levels | GCST90469615 | 9.02 |
| 510 | FGFR2 levels | GCST90469233 | 8.99 |
| 511 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T369 | ECGU000369 | 8.99 |
| 512 | Heart valve disorders (PheCode 395) | GCST90475913 | 8.96 |
| 513 | Abdominal aortic aneurysm (PheCode 442.11) | GCST90475994 | 8.96 |
| 514 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T367 | ECGU000367 | 8.95 |
| 515 | IDP dMRI TBSS L2 Sagittal stratum L | GCST90004154 | 8.94 |
| 516 | T1 CAT volume Vermis VIIIa | GCST90384128 | 8.92 |
| 517 | COL4A1 levels | GCST90468818 | 8.91 |
| 518 | Follicular cysts of skin and subcutaneous tissue | FING00000547 | 8.90 |
| 519 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T32 | ECGA000032 | 8.87 |
| 520 | PTPRS levels | GCST90470387 | 8.85 |
| 521 | DTI TBSS L2 Retrolenticular part of internal capsule L | GCST90384497 | 8.84 |
| 522 | CD164/PARK7 ratio | GCST90313743 | 8.84 |
| 523 | APOA2 levels | GCST90468332 | 8.81 |
| 524 | Blood cell traits latent factor 20 (red cell) | GCST90559262 | 8.81 |
| 525 | Retinal breaks without detachment | FING00001258 | 8.80 |
| 526 | SMOC1 levels | GCST90470682 | 8.79 |
| 527 | Operation code - varicose vein surgery | Operations | UKBB00000568 | 8.78 |
| 528 | ERBIN/TBC1D23 ratio | GCST90314698 | 8.78 |
| 529 | CDON levels | GCST90468687 | 8.76 |
| 530 | Spinal stenosis | musculoskeletal | UKBB00000792 | 8.76 |
| 531 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T375 | ECGU000375 | 8.75 |
| 532 | Volume of right cortico-amygdaloid transition area | GCST90475018 | 8.72 |
| 533 | Ankle spacing width (left) | Bone-densitometry of heel | UKBB00000033 | 8.71 |
| 534 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T30 | ECGA000030 | 8.71 |
| 535 | wg lh intensity-contrast caudalmiddlefrontal | GCST90003795 | 8.70 |
| 536 | Glaucoma (primary open-angle) | GCST90011766 | 8.70 |
| 537 | aparc-DKTatlas rh thickness paracentral | GCST90003586 | 8.67 |
| 538 | Diverticulosis (PheCode 562.1) | GCST90476076 | 8.67 |
| 539 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 26) | GCST90320845 | 8.67 |
| 540 | LAMA4 levels | GCST90469731 | 8.63 |
| 541 | IDP dMRI ProbtrackX FA str l | GCST90003948 | 8.63 |
| 542 | aparc-Desikan rh volume lateraloccipital | GCST90002811 | 8.63 |
| 543 | aseg lh volume Putamen | GCST90002622 | 8.63 |
| 544 | TP53I3 levels | GCST90470937 | 8.61 |
| 545 | Cardiovascular delta age (difference between cardiac MRI-predicted and chronological age) | GCST90239748 | 8.61 |
| 546 | Barrett's esophagus | GCST003738 | 8.60 |
| 547 | CCDC80/CHRDL1 ratio | GCST90313670 | 8.59 |
| 548 | ESAM/LAMA4 ratio | GCST90314713 | 8.58 |
| 549 | HHIP levels | GCST90617097 | 8.58 |
| 550 | Triacylglycerol_46:4_[M+NH4]1+ levels | GCST90060362 | 8.57 |
| 551 | DTI autoptx L3 str l tract | GCST90385216 | 8.56 |
| 552 | HRC levels | GCST90469475 | 8.55 |
| 553 | GPD1 levels | GCST90469388 | 8.55 |
| 554 | DTI autoptx L2 unc l tract | GCST90385191 | 8.54 |
| 555 | Heart valve replaced (PheCode 395.6) | GCST90475915 | 8.54 |
| 556 | Heart attack | GCST90468132 | 8.54 |
| 557 | LPCAT2 levels | GCST90241841 | 8.52 |
| 558 | aparc-Desikan lh area lingual | GCST90003085 | 8.52 |
| 559 | DTI TBSS MD Retrolenticular part of internal capsule L | GCST90384593 | 8.50 |
| 560 | Appendicular lean mass | GCST90000026 | 8.49 |
| 561 | aparc-DKTatlas rh thickness postcentral | GCST90003591 | 8.47 |
| 562 | aparc-a2009s rh thickness G-postcentral | GCST90003704 | 8.43 |
| 563 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 72) | GCST90320891 | 8.41 |
| 564 | RAPGEF2 levels | GCST90470426 | 8.40 |
| 565 | EGFLAM levels | GCST90421651 | 8.39 |
| 566 | Hand grip strength (right) | Hand grip strength | UKBB00000301 | 8.39 |
| 567 | Autorefraction - 3mm cylindrical power (right) | Eyesight | UKBB00000063 | 8.38 |
| 568 | Glaucoma suspect | FING00000579 | 8.38 |
| 569 | UBXN1 levels | GCST90471004 | 8.37 |
| 570 | IDP dMRI ProbtrackX L1 ptr l | GCST90004265 | 8.35 |
| 571 | INHBB levels | GCST90469614 | 8.34 |
| 572 | PAMR1 levels | GCST90470155 | 8.34 |
| 573 | CCN1/DNAJB1 ratio | GCST90313709 | 8.32 |
| 574 | IGFBP4/OGN ratio | GCST90315134 | 8.31 |
| 575 | BA-exvivo rh volume BA3b | GCST90002852 | 8.29 |
| 576 | height (mean, inv-normal transformed) | GCST90475362 | 8.27 |
| 577 | DKKL1 levels | GCST90469000 | 8.27 |
| 578 | MSRA/P4HB ratio | GCST90315495 | 8.26 |
| 579 | wg lh intensity-contrast inferiortemporal | GCST90003800 | 8.22 |
| 580 | IDP dMRI ProbtrackX L2 ifo l | GCST90004285 | 8.22 |
| 581 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 84) | GCST90320903 | 8.22 |
| 582 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T368 | ECGU000368 | 8.22 |
| 583 | CLMP/TGFBR2 ratio | GCST90314135 | 8.20 |
| 584 | aparc-DKTatlas rh volume lateraloccipital | GCST90002902 | 8.19 |
| 585 | BA-exvivo lh volume BA3a | GCST90002837 | 8.18 |
| 586 | Height (maximum, inv-normal transformed) | GCST90475359 | 8.14 |
| 587 | aparc-DKTatlas lh area lingual | GCST90003245 | 8.13 |
| 588 | Operation code - carpal tunnel surgery | Operations | UKBB00000553 | 8.13 |
| 589 | Systolic blood pressure | GCST90301697 | 8.12 |
| 590 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 123) | GCST90320686 | 8.10 |
| 591 | ADGRD1 levels | GCST90468235 | 8.08 |
| 592 | Intraocular pressure | GCST004074 | 8.08 |
| 593 | Diaphragmatic hernia | digestive | UKBB00000171 | 8.08 |
| 594 | aparc-DKTatlas lh volume precentral | GCST90002884 | 8.06 |
| 595 | LTBP2 levels | GCST90469814 | 8.05 |
| 596 | Torso length to body height ratio | GCST90270262 | 8.05 |
| 597 | ADAM9 levels | GCST90468221 | 8.04 |
| 598 | DTI autoptx L3 atr l tract | GCST90385195 | 8.04 |
| 599 | aparc-Desikan lh thickness GlobalMeanThickness | GCST90003445 | 8.01 |
| 600 | IDP T1 FAST ROIs L cerebellum IX | GCST90002584 | 8.00 |
| 601 | CDHR2 levels | GCST90468679 | 8.00 |
| 602 | aparc-a2009s rh volume S-subparietal | GCST90003069 | 7.98 |
| 603 | DPP4/ITGB1 ratio | GCST90314540 | 7.98 |
| 604 | Valine levels | GCST90243453 | 7.97 |
| 605 | IDP dMRI TBSS OD Fornix | GCST90004407 | 7.96 |
| 606 | Maximum indexed left atrial volume | GCST90019012 | 7.95 |
| 607 | CKAP2 levels | GCST90240866 | 7.94 |
| 608 | Ganglion and cyst of synovium, tendon, and bursa (PheCode 727.4) | GCST90476243 | 7.92 |
| 609 | Coronary artery plaque burden | GCST90503075 | 7.92 |
| 610 | Height | GCST90018739 | 7.89 |
| 611 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502593 | 7.89 |
| 612 | IDP dMRI ProbtrackX MD ifo r | GCST90004232 | 7.88 |
| 613 | CCN5/IGFBP6 ratio | GCST90313723 | 7.88 |
| 614 | aparc-Desikan rh thickness paracentral | GCST90003495 | 7.87 |
| 615 | Glaucoma | FING00000577 | 7.86 |
| 616 | Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers) | FING00000771 | 7.86 |
| 617 | ITGAM/ITGAV ratio | GCST90315209 | 7.84 |
| 618 | IDP dMRI ProbtrackX L1 ilf r | GCST90004261 | 7.83 |
| 619 | FUS levels | GCST90469278 | 7.80 |
| 620 | Succinylcarnitine levels | GCST90243874 | 7.78 |
| 621 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 59) | GCST90320878 | 7.77 |
| 622 | Volume of left lateral nucleus | GCST90474970 | 7.77 |
| 623 | IDP dMRI ProbtrackX ISOVF fma | GCST90004535 | 7.76 |
| 624 | Left-hemisphere control network to thalamus white-matter structural connectivity | GCST90302752 | 7.75 |
| 625 | aparc-Desikan rh thickness transversetemporal | GCST90003511 | 7.74 |
| 626 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T8 | ECGA000008 | 7.74 |
| 627 | BA-exvivo rh volume BA1 | GCST90002849 | 7.72 |
| 628 | OLR1 levels | GCST90012020 | 7.68 |
| 629 | Total body bone mineral density (age 45-60) | GCST005350 | 7.68 |
| 630 | aparc-Desikan lh volume parsopercularis | GCST90002785 | 7.67 |
| 631 | Acquired foot deformities (PheCode 735) | GCST90476247 | 7.65 |
| 632 | aparc-Desikan lh volume lingual | GCST90002780 | 7.64 |
| 633 | Osteoarthrosis NOS | musculoskeletal | UKBB00000597 | 7.64 |
| 634 | Autorefraction - 3mm cylindrical power angle (left) | Eyesight | UKBB00000064 | 7.63 |
| 635 | LY75 levels | GCST90469822 | 7.63 |
| 636 | Total thigh muscle volume z-score | GCST90267356 | 7.62 |
| 637 | DTI TBSS L2 Uncinate fasciculus L | GCST90384521 | 7.62 |
| 638 | IDP dMRI ProbtrackX MD fmi | GCST90004230 | 7.62 |
| 639 | TALDO1 levels | GCST90470802 | 7.62 |
| 640 | Prolapse of vaginal walls | genitourinary | UKBB00000712 | 7.61 |
| 641 | Other disorders of eyelid | FING00001026 | 7.60 |
| 642 | Left-hemisphere default mode network to right-hemisphere visual network white-matter structural connectivity | GCST90302760 | 7.59 |
| 643 | Total protein levels | GCST90025995 | 7.58 |
| 644 | OMD levels | GCST90470123 | 7.57 |
| 645 | PON1 levels | GCST90470285 | 7.57 |
| 646 | Abdominal aortic aneurysm (AAA) | FING00000001 | 7.56 |
| 647 | HGF/TNFSF14 ratio | GCST90315060 | 7.56 |
| 648 | CD40LG/EREG ratio | GCST90313820 | 7.55 |
| 649 | IDP dMRI ProbtrackX MD ar r | GCST90004220 | 7.54 |
| 650 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 97) | GCST90320916 | 7.52 |
| 651 | Femoral hernia | FING00000540 | 7.52 |
| 652 | aparc-DKTatlas lh volume parsopercularis | GCST90002878 | 7.52 |
| 653 | Lung cancer | GCST90011812 | 7.52 |
| 654 | IDP dMRI ProbtrackX L3 fmi | GCST90004311 | 7.51 |
| 655 | FGR levels | GCST90469236 | 7.51 |
| 656 | MSMB levels | GCST90469949 | 7.49 |
| 657 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T370 | ECGU000370 | 7.47 |
| 658 | aparc-Desikan lh volume cuneus | GCST90002772 | 7.46 |
| 659 | Autorefraction - 3mm weak meridian angle (left) | Eyesight | UKBB00000071 | 7.45 |
| 660 | height (minimum, inv-normal transformed) | GCST90475365 | 7.43 |
| 661 | MFAP4 levels | GCST90469898 | 7.43 |
| 662 | IDP dMRI ProbtrackX MD fma | GCST90004229 | 7.42 |
| 663 | Illnesses of mother - None of the above (group 1) | Family history | UKBB00000349 | 7.42 |
| 664 | COL3A1 levels | GCST90468817 | 7.38 |
| 665 | End-diastolic bi-ventricular shape (principal component 9) | GCST90448488 | 7.37 |
| 666 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T364 | ECGU000364 | 7.37 |
| 667 | IDP dMRI ProbtrackX L3 ar l | GCST90004300 | 7.37 |
| 668 | ROBO1/SPON1 ratio | GCST90315783 | 7.36 |
| 669 | Sexual abuse | GCST90551837 | 7.35 |
| 670 | Acylcarnitine (18:2) levels | GCST90024623 | 7.34 |
| 671 | IDP dMRI TBSS MD Cingulum hippocampus R | GCST90004063 | 7.33 |
| 672 | Hydrocele | FING00000627 | 7.33 |
| 673 | COLEC12/TGFBR2 ratio | GCST90314186 | 7.32 |
| 674 | aseg rh intensity Accumbens-area | GCST90003788 | 7.31 |
| 675 | Metabolic disorder, other/unspecified | FING00000815 | 7.30 |
| 676 | BA-exvivo lh volume BA3b | GCST90002838 | 7.30 |
| 677 | PARK7/TNFRSF9 ratio | GCST90315599 | 7.29 |
| 678 | Benign neoplasm: Colon, unspecified | FING00000172 | 7.29 |
| 679 | CD109 levels | GCST90468597 | 7.28 |
| 680 | IL16 levels | GCST90241596 | 7.28 |
| 681 | Standing height | Body size measures | UKBB00000796 | 7.27 |
| 682 | Operation code - inguinal hernia repair | Operations | UKBB00000560 | 7.27 |
| 683 | Macular degeneration, dry (PheCode 362.21) | GCST90475851 | 7.26 |
| 684 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T374 | ECGU000374 | 7.26 |
| 685 | triglyceride (minimum, inv-norm transformed) | GCST90476439 | 7.26 |
| 686 | aparc-DKTatlas rh thickness transversetemporal | GCST90003601 | 7.25 |
| 687 | Volume of right accessory basal nucleus | GCST90474907 | 7.25 |
| 688 | HippSubfield lh volume GC-ML-DG-body | GCST90002681 | 7.24 |
| 689 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 41) | GCST90320860 | 7.22 |
| 690 | Retinal thickness (functional principal component 6) | GCST90455726 | 7.22 |
| 691 | Sleep apnea with BMI < 30 | GCST90624797 | 7.21 |
| 692 | CCL27 levels | GCST90468579 | 7.21 |
| 693 | ACYP1 levels | GCST90468214 | 7.20 |
| 694 | Hydrocele (PheCode 603.1) | GCST90476157 | 7.20 |
| 695 | C3 levels | GCST90468498 | 7.19 |
| 696 | Non-cancer illness code, self-reported - angina | Medical conditions | UKBB00000505 | 7.19 |
| 697 | SRSF7 levels | GCST90242771 | 7.16 |
| 698 | T1 FreeSurfer DK lh lingual thickness | GCST90385634 | 7.15 |
| 699 | IDP dMRI TBSS L2 Posterior corona radiata R | GCST90004149 | 7.15 |
| 700 | ESR1 levels | GCST90469155 | 7.14 |
| 701 | IDP T1 FAST ROIs L cerebellum VIIIb | GCST90002581 | 7.14 |
| 702 | IDP dMRI ProbtrackX L2 ifo r | GCST90004286 | 7.13 |
| 703 | rfMRI connectivity (ICA100 edge 380) | GCST90005233 | 7.13 |
| 704 | Other cataract | Disorders of lens | UKBB00000602 | 7.13 |
| 705 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T376 | ECGU000376 | 7.13 |
| 706 | Hip circumference adjusted for BMI | GCST90020028 | 7.12 |
| 707 | CD48 levels | GCST90425676 | 7.09 |
| 708 | Medication use (antiglaucoma preparations and miotics) | GCST90018782 | 7.08 |
| 709 | ITGAV levels | GCST90469639 | 7.08 |
| 710 | Volume of right whole amygdala | GCST90475054 | 7.05 |
| 711 | T1 FreeSurfer a2009s lh G cuneus area | GCST90384678 | 7.04 |
| 712 | ERBB3 levels | GCST90469140 | 7.02 |
| 713 | wg rh intensity-contrast parsopercularis | GCST90003844 | 7.01 |
| 714 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T230 | ECGA000230 | 7.01 |
| 715 | CHRDL1/SMOC2 ratio | GCST90314062 | 7.01 |
| 716 | Autorefraction - 6mm asymmetry angle (left) | Eyesight | UKBB00000072 | 7.00 |
| 717 | aparc-Desikan rh area parsopercularis | GCST90003124 | 7.00 |
| 718 | Other hammer toe(s) (acquired) | FING00001054 | 6.99 |
| 719 | BA-exvivo rh thickness BA2 | GCST90003528 | 6.97 |
| 720 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T7 | ECGA000007 | 6.96 |
| 721 | NCS1/NPY ratio | GCST90315527 | 6.95 |
| 722 | BA-exvivo rh thickness BA3b | GCST90003530 | 6.94 |
| 723 | Coronary atherosclerosis (PheCode 411.4) | GCST90043957 | 6.93 |
| 724 | PPP2R2A levels | GCST90618122 | 6.92 |
| 725 | Left-hemisphere dorsal attention network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302696 | 6.92 |
| 726 | IDP dMRI ProbtrackX L2 atr l | GCST90004275 | 6.91 |
| 727 | Bone marrow fat fraction of left proximal femur | GCST90652392 | 6.91 |
| 728 | COL6A3 levels | GCST90468821 | 6.90 |
| 729 | Degeneration of macula and posterior pole of retina (PheCode 362.2) | GCST90475849 | 6.90 |
| 730 | Pelvic organ prolapse | GCST90102470 | 6.88 |
| 731 | Pelvic height | GCST90448912 | 6.87 |
| 732 | NPY/SMOC1 ratio | GCST90315551 | 6.86 |
| 733 | Tyrosine levels | GCST90243425 | 6.83 |
| 734 | TNFRSF14/TNFSF14 ratio | GCST90315936 | 6.82 |
| 735 | aparc-Desikan rh volume parahippocampal | GCST90002816 | 6.82 |
| 736 | Inguinal hernia, bilateral | FING00000682 | 6.81 |
| 737 | GMPR2 levels | GCST90469367 | 6.79 |
| 738 | aseg lh intensity Accumbens-area | GCST90003774 | 6.77 |
| 739 | Depression/anxiety (weighted GWA) | GCST90267277 | 6.77 |
| 740 | aparc-DKTatlas lh area entorhinal | GCST90003238 | 6.77 |
| 741 | IDP dMRI ProbtrackX FA ilf r | GCST90003940 | 6.75 |
| 742 | IDP dMRI TBSS L3 Fornix | GCST90004176 | 6.75 |
| 743 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T12 | ECGU000012 | 6.74 |
| 744 | IRF2 levels | GCST90241566 | 6.74 |
| 745 | Cerebrospinal fluid 3-hydroxyhexanoate levels | GCST90318108 | 6.72 |
| 746 | aparc-DKTatlas rh volume parahippocampal | GCST90002907 | 6.71 |
| 747 | aparc-a2009s rh area G-pariet-inf-Angular | GCST90003395 | 6.70 |
| 748 | Left-hemisphere salience/ventral attention network to thalamus white-matter structural connectivity | GCST90302719 | 6.69 |
| 749 | Cholesteryl ester (16:2) levels | GCST90024628 | 6.68 |
| 750 | Volume of left accessory basal nucleus | GCST90474940 | 6.67 |
| 751 | ANGPT2 levels | GCST90468301 | 6.67 |
| 752 | Retinal arteriolar width | GCST90270398 | 6.67 |
| 753 | aparc-DKTatlas lh volume lingual | GCST90002873 | 6.66 |
| 754 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 62) | GCST90320625 | 6.65 |
| 755 | Testosterone levels | GCST90483486 | 6.64 |
| 756 | Diacylglycerol_38:5_[M+H-H2O]1+ levels | GCST90060200 | 6.64 |
| 757 | Pulse wave reflection index | Arterial stiffness | UKBB00000726 | 6.62 |
| 758 | IDP dMRI ProbtrackX L2 fmi | GCST90004284 | 6.61 |
| 759 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T31 | ECGA000031 | 6.61 |
| 760 | ITGA11 levels | GCST90469633 | 6.60 |
| 761 | aparc-a2009s rh volume S-orbital-H-Shaped | GCST90003062 | 6.60 |
| 762 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T24 | ECGU000024 | 6.60 |
| 763 | Treatment speciality of consultant (recoded) - Ophthalmology | Summary Administration | UKBB00000835 | 6.60 |
| 764 | ALB levels | GCST90475103 | 6.60 |
| 765 | FGF19 levels | GCST90469220 | 6.59 |
| 766 | SLC39A5 levels | GCST90470661 | 6.59 |
| 767 | Deep bite | FING00000380 | 6.57 |
| 768 | Chronic rhinitis, nasopharyngitis and pharyngitis | FING00000297 | 6.57 |
| 769 | ICD10 N81: Female genital prolapse | GCST90454214 | 6.56 |
| 770 | Thoracic or lumbosacral neuritis or radiculitis, unspecified (PheCode 763) | GCST90476268 | 6.56 |
| 771 | Forced vital capacity (FVC) | Spirometry | UKBB00000254 | 6.56 |
| 772 | Perforation of tympanic membrane | FING00001155 | 6.56 |
| 773 | Operative procedures - Anastomosis of mammary artery to left anterior descending coronary artery | Summary Operations | UKBB00000571 | 6.55 |
| 774 | PTPN1/TDRKH ratio | GCST90315745 | 6.55 |
| 775 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T235 | ECGA000235 | 6.53 |
| 776 | Diarrhoea and gastroenteritis of presumed infectious origin | FING00000420 | 6.51 |
| 777 | FAP/THBS4 ratio | GCST90314785 | 6.50 |
| 778 | Genital prolapse | genitourinary | UKBB00000282 | 6.50 |
| 779 | DNAJC9 levels | GCST90469018 | 6.50 |
| 780 | Primary angle-closure glaucoma (PheCode 365.2) | GCST90475876 | 6.49 |
| 781 | triglyceride (mean, inv-norm transformed) | GCST90476435 | 6.49 |
| 782 | ASPN levels | GCST90468377 | 6.48 |
| 783 | IDP dMRI TBSS L3 Retrolenticular part of internal capsule R | GCST90004191 | 6.48 |
| 784 | Phosphatidylcholine-O_34:3_[M+H]1+/Phosphatidylcholine-P_34:2_[M+H]1+/Phosphatidylethanolamine-P_37:2_[M+H]1+ levels | GCST90060277 | 6.48 |
| 785 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T416 | ECGA000416 | 6.47 |
| 786 | PTPRH levels | GCST90470382 | 6.47 |
| 787 | DAB2/TBL1X ratio | GCST90314368 | 6.46 |
| 788 | Cerebrovascular disease (PheCode 433) | GCST90475985 | 6.45 |
| 789 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 75) | GCST90320894 | 6.45 |
| 790 | Ventral hernia | FING00001428 | 6.43 |
| 791 | Left-hemisphere salience/ventral attention network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302715 | 6.42 |
| 792 | TDRKH levels | GCST90470827 | 6.42 |
| 793 | Hippocampal right GC-ML-DG volume (head) | GCST90267968 | 6.41 |
| 794 | wg rh intensity-contrast caudalmiddlefrontal | GCST90003830 | 6.41 |
| 795 | Other predominantly sexually transmitted diseases, not elsewhere classified | FING00001089 | 6.41 |
| 796 | Operative procedures - Insertion of prosthetic replacement for lens NEC | Summary Operations | UKBB00000583 | 6.40 |
| 797 | CHCHD6 levels | GCST90468739 | 6.39 |
| 798 | IDP dMRI TBSS MD Posterior thalamic radiation L | GCST90004056 | 6.39 |
| 799 | ITGB1 levels | GCST90469643 | 6.39 |
| 800 | Heart failure and coronary heart disease | FING00000604 | 6.39 |
| 801 | systolic blood pressure (SBP, mean, inv-normal transformed) | GCST90476403 | 6.38 |
| 802 | What is your height? (cm, inv-normal transformed) | GCST90475368 | 6.38 |
| 803 | Hammer toe (acquired) (PheCode 735.21) | GCST90476250 | 6.38 |
| 804 | XRCC4 levels | GCST90471085 | 6.38 |
| 805 | Mean carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasound | UKBB00000445 | 6.37 |
| 806 | PSPN levels | GCST90470364 | 6.37 |
| 807 | Urine glucuronide of C10H18O2 (12)* levels in chronic kidney disease | GCST90265189 | 6.37 |
| 808 | aparc-a2009s lh area S-collat-transv-ant | GCST90003346 | 6.36 |
| 809 | Corneal opacity and other disorders of cornea (PheCode 364) | GCST90475861 | 6.36 |
| 810 | FABP4 levels | GCST90012075 | 6.35 |
| 811 | systolic blood pressure (SBP, maximum, inv-normal transformed) | GCST90476400 | 6.35 |
| 812 | aparc-a2009s rh area G+S-occipital-inf | GCST90003372 | 6.33 |
| 813 | DNAJA2/FIS1 ratio | GCST90314501 | 6.32 |
| 814 | ThalamNuclei lh volume CeM | GCST90002725 | 6.32 |
| 815 | Umbilical hernia | FING00001395 | 6.31 |
| 816 | rfMRI connectivity ICA-features 4 | GCST90006342 | 6.31 |
| 817 | Urinary ethanolamine to urinary creatinine ratio | GCST90451717 | 6.30 |
| 818 | Tetradecadienedioate (C14:2-DC) metabolite level | GCST90616275 | 6.29 |
| 819 | IDP dMRI ProbtrackX MD atr l | GCST90004221 | 6.29 |
| 820 | Other peripheral nerve disorders (PheCode 351) | GCST90475842 | 6.29 |
| 821 | wg lh intensity-contrast superiorfrontal | GCST90003819 | 6.29 |
| 822 | triglyceride (maximum, inv-norm transformed) | GCST90476431 | 6.28 |
| 823 | OLR1/PLAUR ratio | GCST90315584 | 6.27 |
| 824 | IDP dMRI ProbtrackX L2 ar l | GCST90004273 | 6.26 |
| 825 | IGBP1 levels | GCST90469521 | 6.24 |
| 826 | Other diseases of intestines | FING00001001 | 6.24 |
| 827 | aparc-DKTatlas rh area lingual | GCST90003276 | 6.24 |
| 828 | CNTN4 levels | GCST90468806 | 6.24 |
| 829 | heart rate (HR, minimum, inv-normal transformed) | GCST90476341 | 6.23 |
| 830 | Sphingomyelin (d17:1/16:0, d18:1/15:0, d16:1/17:0) levels | GCST90200017 | 6.23 |
| 831 | BA-exvivo rh area V1 | GCST90003230 | 6.23 |
| 832 | MED18/SMAD1 ratio | GCST90315413 | 6.23 |
| 833 | CD69/TXNDC5 ratio | GCST90313889 | 6.22 |
| 834 | CCL8 levels | GCST90422346 | 6.21 |
| 835 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502166 | 6.21 |
| 836 | Hereditary corneal dystrophies | FING00000611 | 6.21 |
| 837 | Systolic blood pressure (weighted GWA) | GCST90267305 | 6.21 |
| 838 | Left ventricular end systole anterolateral wall thickness | GCST90278511 | 6.19 |
| 839 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T26 | ECGA000026 | 6.19 |
| 840 | Forearm length to body height ratio | GCST90270257 | 6.18 |
| 841 | NOS3 levels | GCST90470064 | 6.18 |
| 842 | NXPH3 levels | GCST90470112 | 6.17 |
| 843 | T1 FreeSurfer aseg Right-Lateral-Ventricle | GCST90384157 | 6.17 |
| 844 | IDP dMRI TBSS OD Superior corona radiata R | GCST90004426 | 6.17 |
| 845 | CST6/NECTIN4 ratio | GCST90314303 | 6.17 |
| 846 | KIAA0040 levels | GCST90422552 | 6.17 |
| 847 | Milk type used: Soy milk vs never have milk (UKB data field 1418) | GCST90132943 | 6.16 |
| 848 | Peritonsillar abscess | FING00001160 | 6.15 |
| 849 | DPT levels | GCST90469036 | 6.15 |
| 850 | Angina pectoris | Ischaemic heart diseases | UKBB00000031 | 6.13 |
| 851 | Thoracic aortic aneurysm | FING00001357 | 6.13 |
| 852 | HHEX levels | GCST90469451 | 6.12 |
| 853 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T417 | ECGA000417 | 6.12 |
| 854 | CCL19 levels | GCST90274765 | 6.10 |
| 855 | aparc-DKTatlas lh volume cuneus | GCST90002865 | 6.10 |
| 856 | Spinal stenosis (PheCode 720) | GCST90476233 | 6.09 |
| 857 | Height | GCST90302890 | 6.08 |
| 858 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T34 | ECGA000034 | 6.08 |
| 859 | IDP dMRI TBSS MD Superior longitudinal fasciculus L | GCST90004068 | 6.07 |
| 860 | TPM2 levels | GCST90243122 | 6.07 |
| 861 | VIT levels | GCST90471041 | 6.07 |
| 862 | DTI TBSS MD Superior fronto-occipital fasciculus L | GCST90384615 | 6.06 |
| 863 | IDP T1 FAST ROIs R caudate | GCST90002550 | 6.05 |
| 864 | ITGBL1 levels | GCST90469648 | 6.04 |
| 865 | aparc-Desikan rh volume parsopercularis | GCST90002818 | 6.04 |
| 866 | Triacylglycerol_49:3_[M+NH4]1+ levels | GCST90060443 | 6.04 |
| 867 | CD40LG/TNFSF14 ratio | GCST90313827 | 6.03 |
| 868 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T403 | ECGA000403 | 6.03 |
| 869 | Anterior thigh muscle volume | GCST90267349 | 6.03 |
| 870 | HSPG2/VASN ratio | GCST90315094 | 6.02 |
| 871 | F11R/PARK7 ratio | GCST90314723 | 6.02 |
| 872 | IDP dMRI TBSS L2 Cerebral peduncle R | GCST90004137 | 6.02 |
| 873 | ICD10 N84: Polyp of female genital tract | GCST90454216 | 6.01 |
| 874 | Acetate levels | GCST90092803 | 6.01 |
| 875 | IDP dMRI TBSS L3 Retrolenticular part of internal capsule L | GCST90004192 | 5.99 |
| 876 | NRP1 levels | GCST90470085 | 5.99 |
| 877 | Use of antiglaucoma preparations and miotics | FING00001409 | 5.99 |
| 878 | ERP44 levels | GCST90469150 | 5.99 |
| 879 | CTSD/PRCP ratio | GCST90314312 | 5.97 |
| 880 | IDP dMRI ProbtrackX L1 ifo l | GCST90004258 | 5.97 |
| 881 | End-diastolic bi-ventricular shape (principal component 4) | GCST90448483 | 5.96 |
| 882 | Pulse pressure (BMI adjusted) | GCST90335167 | 5.96 |
| 883 | TINAGL1 levels | GCST90470873 | 5.96 |
| 884 | FUT8/VEGFC ratio | GCST90314896 | 5.94 |
| 885 | Operative procedures - Unspecified diagnostic endoscopic examination of bladder | Summary Operations | UKBB00000590 | 5.93 |
| 886 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T378 | ECGU000378 | 5.93 |
| 887 | RNASEH2A levels | GCST90470480 | 5.93 |
| 888 | RAD23B levels | GCST90470418 | 5.92 |
| 889 | IDP dMRI ProbtrackX OD str r | GCST90004474 | 5.92 |
| 890 | Secondary hypertension | FING00001285 | 5.92 |
| 891 | Major coronary heart disease event | FING00000746 | 5.91 |
| 892 | SCARF2 levels | GCST90470537 | 5.90 |
| 893 | Fibromuscular dysplasia | GCST90026612 | 5.90 |
| 894 | CCDC80 levels | GCST90468562 | 5.89 |
| 895 | aparc-a2009s lh area G-cuneus | GCST90003307 | 5.89 |
| 896 | DTI autoptx FA unc r tract | GCST90385138 | 5.89 |
| 897 | Vascular/heart problems diagnosed by doctor - Angina | Medical conditions | UKBB00000896 | 5.88 |
| 898 | Intracerebral hemorrhage | GCST90018650 | 5.88 |
| 899 | wg rh intensity-contrast parsorbitalis | GCST90003845 | 5.87 |
| 900 | TNFSF11 levels | GCST90012044 | 5.87 |
| 901 | Vascular/heart problems diagnosed by doctor - Heart attack | Medical conditions | UKBB00000897 | 5.87 |
| 902 | FNDC1 levels | GCST90469256 | 5.87 |
| 903 | IDP dMRI ProbtrackX FA ifo r | GCST90003938 | 5.87 |
| 904 | VSNL1 levels | GCST90471054 | 5.85 |
| 905 | Free androgen index | GCST90239824 | 5.84 |
| 906 | SERPING1 levels | GCST90470600 | 5.84 |
| 907 | MXRA8 levels | GCST90469968 | 5.84 |
| 908 | SNCA levels | GCST90470694 | 5.84 |
| 909 | Nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [LDH] (PheCode 573.6) | GCST90476094 | 5.83 |
| 910 | N-acetyl-2-aminoadipate levels | GCST90200268 | 5.82 |
| 911 | ADGRB3 levels | GCST90468234 | 5.81 |
| 912 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T13 | ECGU000013 | 5.80 |
| 913 | HSPG2 levels | GCST90179392 | 5.79 |
| 914 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T25 | ECGU000025 | 5.79 |
| 915 | ADAMTSL2 levels | GCST90468228 | 5.79 |
| 916 | Corneal dystrophy (PheCode 364.5) | GCST90475864 | 5.79 |
| 917 | LAMA4/NID1 ratio | GCST90315272 | 5.78 |
| 918 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T404 | ECGA000404 | 5.78 |
| 919 | IDP dMRI ProbtrackX L3 atr l | GCST90004302 | 5.78 |
| 920 | CA2/TGM2 ratio | GCST90313582 | 5.77 |
| 921 | Triacylglycerol (52:4) [NL-16:0] levels | GCST90025170 | 5.77 |
| 922 | Optic cup area | GCST004137 | 5.75 |
| 923 | IDP dMRI TBSS MD Fornix | GCST90004032 | 5.74 |
| 924 | APP/NID2 ratio | GCST90313327 | 5.74 |
| 925 | aseg global intensity WM-hypointensities | GCST90003756 | 5.74 |
| 926 | Phosphatidylcholine-O_36:2_[M+H]1+/Phosphatidylcholine-P_36:1_[M+H]1+/Phosphatidylethanolamine-P_39:1_[M+H]1+ levels | GCST90060326 | 5.73 |
| 927 | wg lh intensity-contrast bankssts | GCST90003793 | 5.73 |
| 928 | IDP dMRI TBSS ICVF Cingulum hippocampus R | GCST90004363 | 5.72 |
| 929 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 122) | GCST90320941 | 5.72 |
| 930 | Spherical power (left) | Autorefraction | UKBB00000790 | 5.72 |
| 931 | Prescriptions - losartan | angiotensin receptor blocker,anti-hypertensive,ARB | UKBB00000690 | 5.71 |
| 932 | Trunk fat percentage | Impedance measures | UKBB00000864 | 5.71 |
| 933 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T11 | ECGU000011 | 5.71 |
| 934 | IDP dMRI ProbtrackX L3 ar r | GCST90004301 | 5.70 |
| 935 | X-26109 levels | GCST90200671 | 5.70 |
| 936 | aparc-Desikan rh area lingual | GCST90003119 | 5.69 |
| 937 | Angina pectoris | circulatory system | UKBB00000030 | 5.69 |
| 938 | IDP dMRI TBSS MD Cingulum cingulate gyrus R | GCST90004061 | 5.69 |
| 939 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 39) | GCST90320858 | 5.69 |
| 940 | MB levels | GCST90012047 | 5.68 |
| 941 | BA-exvivo lh area V2 | GCST90003217 | 5.68 |
| 942 | MIA levels | GCST90469903 | 5.67 |
| 943 | aseg global volume 4th-Ventricle | GCST90002600 | 5.67 |
| 944 | Disorders of breast | FING00000437 | 5.66 |
| 945 | Sitting height | Body size measures | UKBB00000771 | 5.66 |
| 946 | BA-exvivo rh volume BA3a | GCST90002851 | 5.66 |
| 947 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T363 | ECGU000363 | 5.65 |
| 948 | MTIF3 levels | GCST90469957 | 5.65 |
| 949 | Hand grip strength (baseline) | GCST90565845 | 5.64 |
| 950 | CA11 levels | GCST90468506 | 5.64 |
| 951 | X-17676 levels | GCST90200548 | 5.63 |
| 952 | AIFM1/EGF ratio | GCST90313219 | 5.63 |
| 953 | aparc-a2009s rh area S-subparietal | GCST90003441 | 5.62 |
| 954 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 57) | GCST90320620 | 5.62 |
| 955 | LEPR levels | GCST90469756 | 5.61 |
| 956 | IDP dMRI TBSS L2 Cingulum hippocampus R | GCST90004159 | 5.59 |
| 957 | aparc-DKTatlas rh volume precentral | GCST90002915 | 5.58 |
| 958 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T377 | ECGU000377 | 5.58 |
| 959 | CPXM2 levels | GCST90468850 | 5.58 |
| 960 | IDP dMRI TBSS L1 External capsule R | GCST90004107 | 5.57 |
| 961 | METAP1D/PLXNA4 ratio | GCST90315427 | 5.57 |
| 962 | IDP dMRI TBSS MD Posterior thalamic radiation R | GCST90004055 | 5.57 |
| 963 | Operation code - coronary angioplasty (ptca) +/- stent | Operations | UKBB00000555 | 5.56 |
| 964 | Current employment status - Doing unpaid or voluntary work | Employment | UKBB00000157 | 5.56 |
| 965 | PFDN5 levels | GCST90242340 | 5.55 |
| 966 | NTN1 levels | GCST90242047 | 5.55 |
| 967 | DTI TBSS L2 Anterior corona radiata L | GCST90384499 | 5.55 |
| 968 | Barrett's esophagus or Esophageal adenocarcinoma | GCST003740 | 5.54 |
| 969 | IDP dMRI TBSS MD Cingulum cingulate gyrus L | GCST90004062 | 5.53 |
| 970 | Metabolonic lactone sulfate levels | GCST90200257 | 5.52 |
| 971 | Eye autorefraction and astigmatism (confirmatory factor analysis Factor 24) | GCST90309358 | 5.52 |
| 972 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T379 | ECGU000379 | 5.52 |
| 973 | Acute appendicitis, no complications | FING00000018 | 5.52 |
| 974 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 106) | GCST90320925 | 5.50 |
| 975 | PLG levels | GCST90470257 | 5.50 |
| 976 | IDP dMRI TBSS MO Retrolenticular part of internal capsule R | GCST90003972 | 5.48 |
| 977 | Retinal detachments and defects | sense organs | UKBB00000756 | 5.47 |
| 978 | heart rate (HR, mean, inv-normal transformed) | GCST90476338 | 5.45 |
| 979 | DTI autoptx L2 atr l tract | GCST90385168 | 5.44 |
| 980 | aparc-Desikan lh volume postcentral | GCST90002789 | 5.44 |
| 981 | Knee extension strength | GCST90319502 | 5.43 |
| 982 | ALB levels | GCST90475100 | 5.42 |
| 983 | BCAN/DPP6 ratio | GCST90313478 | 5.42 |
| 984 | Stroke, excluding SAH | FING00001337 | 5.42 |
| 985 | SNX15 levels | GCST90470699 | 5.39 |
| 986 | wg lh intensity-contrast transversetemporal | GCST90003825 | 5.39 |
| 987 | CD27/FCRL5 ratio | GCST90313772 | 5.37 |
| 988 | Left-hemisphere default mode network to thalamus white-matter structural connectivity | GCST90302767 | 5.36 |
| 989 | Lactose intolerance, other/unspecified | FING00000712 | 5.36 |
| 990 | CHI3L1/HSPG2 ratio | GCST90314043 | 5.35 |
| 991 | COL24A1 levels | GCST90468814 | 5.34 |
| 992 | BA-exvivo lh volume V2 | GCST90002845 | 5.34 |
| 993 | FKBPL levels | GCST90469246 | 5.34 |
| 994 | IDP dMRI TBSS L2 Cingulum hippocampus L | GCST90004160 | 5.34 |
| 995 | CNST/ITGB1BP2 ratio | GCST90314158 | 5.34 |
| 996 | Operation code - coronary artery bypass grafts (cabg) | Operations | UKBB00000556 | 5.32 |
| 997 | Osteopenia or other disorder of bone and cartilage (PheCode 743.9) | GCST90476261 | 5.32 |
| 998 | HAMP levels | GCST90451683 | 5.32 |
| 999 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T408 | ECGA000408 | 5.32 |
| 1000 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 107) | GCST90320670 | 5.31 |